158 related articles for article (PubMed ID: 10222064)
1. TNFalpha and IL-4 regulation of hyaluronan binding to monocyte CD44 involves posttranslational modification of CD44.
Levesque MC; Haynes BF
Cell Immunol; 1999 May; 193(2):209-18. PubMed ID: 10222064
[TBL] [Abstract][Full Text] [Related]
2. Cytokine induction of the ability of human monocyte CD44 to bind hyaluronan is mediated primarily by TNF-alpha and is inhibited by IL-4 and IL-13.
Levesque MC; Haynes BF
J Immunol; 1997 Dec; 159(12):6184-94. PubMed ID: 9550421
[TBL] [Abstract][Full Text] [Related]
3. In vitro culture of human peripheral blood monocytes induces hyaluronan binding and up-regulates monocyte variant CD44 isoform expression.
Levesque MC; Haynes BF
J Immunol; 1996 Feb; 156(4):1557-65. PubMed ID: 8568260
[TBL] [Abstract][Full Text] [Related]
4. Bone morphogenic protein-7 inhibits monocyte-stimulated TGF-beta1 generation in renal proximal tubular epithelial cells.
Zhang XL; Selbi W; de la Motte C; Hascall V; Phillips AO
J Am Soc Nephrol; 2005 Jan; 16(1):79-89. PubMed ID: 15574511
[TBL] [Abstract][Full Text] [Related]
5. Regulation of hyaluronan binding by F-actin and colocalization of CD44 and phosphorylated ezrin/radixin/moesin (ERM) proteins in myeloid cells.
Brown KL; Birkenhead D; Lai JC; Li L; Li R; Johnson P
Exp Cell Res; 2005 Feb; 303(2):400-14. PubMed ID: 15652352
[TBL] [Abstract][Full Text] [Related]
6. Hyaluronan inhibits matrix metalloproteinase-1 production by rheumatoid synovial fibroblasts stimulated by proinflammatory cytokines.
Shimizu M; Yasuda T; Nakagawa T; Yamashita E; Julovi SM; Hiramitsu T; Nakamura T
J Rheumatol; 2003 Jun; 30(6):1164-72. PubMed ID: 12784385
[TBL] [Abstract][Full Text] [Related]
7. Site-specific de-N-glycosylation of CD44 can activate hyaluronan binding, and CD44 activation states show distinct threshold densities for hyaluronan binding.
English NM; Lesley JF; Hyman R
Cancer Res; 1998 Aug; 58(16):3736-42. PubMed ID: 9721887
[TBL] [Abstract][Full Text] [Related]
8. CD44 expression on activated B cells. Differential capacity for CD44-dependent binding to hyaluronic acid.
Hathcock KS; Hirano H; Murakami S; Hodes RJ
J Immunol; 1993 Dec; 151(12):6712-22. PubMed ID: 7505013
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-18 enhances monocyte tumor necrosis factor alpha and interleukin-1beta production induced by direct contact with T lymphocytes: implications in rheumatoid arthritis.
Dai SM; Matsuno H; Nakamura H; Nishioka K; Yudoh K
Arthritis Rheum; 2004 Feb; 50(2):432-43. PubMed ID: 14872485
[TBL] [Abstract][Full Text] [Related]
10. Inducible binding of human lymphocytes to hyaluronate via CD44 does not require cytoskeleton association but does require new protein synthesis.
Murakami S; Shimabukuro Y; Miki Y; Saho T; Hino E; Kasai D; Nozaki T; Kusumoto Y; Okada H
J Immunol; 1994 Jan; 152(2):467-77. PubMed ID: 7506725
[TBL] [Abstract][Full Text] [Related]
11. Binding of CD44 to hyaluronic acid can be induced by multiple signals and requires the CD44 cytoplasmic domain.
Liu D; Zhang D; Mori H; Sy MS
Cell Immunol; 1996 Nov; 174(1):73-83. PubMed ID: 8929456
[TBL] [Abstract][Full Text] [Related]
12. N-terminal and central regions of the human CD44 extracellular domain participate in cell surface hyaluronan binding.
Liao HX; Lee DM; Levesque MC; Haynes BF
J Immunol; 1995 Oct; 155(8):3938-45. PubMed ID: 7561101
[TBL] [Abstract][Full Text] [Related]
13. Regulation of CD44-hyaluronan interactions in Burkitt's lymphoma and Epstein-Barr virus-transformed lymphoblastoid B cells by PMA and interleukin-4.
Kryworuchko M; Gee K; Diaz-Mitoma F; Kumar A
Cell Immunol; 1999 May; 194(1):54-66. PubMed ID: 10357881
[TBL] [Abstract][Full Text] [Related]
14. Absence of functional CD44 hyaluronan receptor on human NMYC-amplified neuroblastoma cells.
Gross N; Balmas K; Brognara CB
Cancer Res; 1997 Apr; 57(7):1387-93. PubMed ID: 9102228
[TBL] [Abstract][Full Text] [Related]
15. Interferon-gamma inhibits CD44-hyaluronan interactions in normal human B lymphocytes.
Kryworuchko M; Diaz-Mitoma F; Kumar A
Exp Cell Res; 1999 Jul; 250(1):241-52. PubMed ID: 10388538
[TBL] [Abstract][Full Text] [Related]
16. Tumor cell-induced deactivation of human monocytes.
Mytar B; Wołoszyn M; Szatanek R; Baj-Krzyworzeka M; Siedlar M; Ruggiero I; Wieckiewicz J; Zembala M
J Leukoc Biol; 2003 Dec; 74(6):1094-101. PubMed ID: 12960282
[TBL] [Abstract][Full Text] [Related]
17. Cutting edge: an inducible sialidase regulates the hyaluronic acid binding ability of CD44-bearing human monocytes.
Katoh S; Miyagi T; Taniguchi H; Matsubara Y; Kadota J; Tominaga A; Kincade PW; Matsukura S; Kohno S
J Immunol; 1999 May; 162(9):5058-61. PubMed ID: 10227973
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of interleukin-1beta-stimulated production of matrix metalloproteinases by hyaluronan via CD44 in human articular cartilage.
Julovi SM; Yasuda T; Shimizu M; Hiramitsu T; Nakamura T
Arthritis Rheum; 2004 Feb; 50(2):516-25. PubMed ID: 14872494
[TBL] [Abstract][Full Text] [Related]
19. Induction of tumor necrosis factor alpha production by adhered human monocytes: a key role for Fcgamma receptor type IIIa in rheumatoid arthritis.
Abrahams VM; Cambridge G; Lydyard PM; Edwards JC
Arthritis Rheum; 2000 Mar; 43(3):608-16. PubMed ID: 10728755
[TBL] [Abstract][Full Text] [Related]
20. Hyaluronan-based polymer scaffold modulates the expression of inflammatory and degradative factors in mesenchymal stem cells: Involvement of Cd44 and Cd54.
Lisignoli G; Cristino S; Piacentini A; Cavallo C; Caplan AI; Facchini A
J Cell Physiol; 2006 May; 207(2):364-73. PubMed ID: 16331675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
